Berlin – A significant proportion of pregnant individuals in the United States are not meeting recommended levels of omega-3 fatty acids, essential nutrients crucial for both maternal and child health, according to a recent nationwide study. The research, published in Public Health Nutrition in February, reveals that approximately 25% of pregnant people rarely or never consume fish, and supplement use remains low, even among those who abstain from seafood. This finding underscores a critical gap in nutritional intake during a period of heightened vulnerability and developmental need.
The study, formally titled “Demographic and health characteristics associated with fish and n-3 fatty acid supplement intake during pregnancy: results from pregnancy cohorts in the ECHO program,” was led by investigators at the Harvard Pilgrim Health Care Institute. Researchers analyzed data from over 10,800 pregnant women regarding their fish consumption and over 12,600 regarding supplement intake, drawing from cohorts participating in the Environmental influences on Child Health Outcomes (ECHO) program, supported by the National Institutes of Health. The ECHO program aims to enhance understanding of factors impacting child health and development.
The Importance of Omega-3s During Pregnancy
Omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), play a vital role in fetal brain and eye development. Adequate intake during pregnancy is linked to improved cognitive function, visual acuity, and reduced risk of preterm birth. The study highlights that getting enough of these nutrients is “vital for preventing preterm birth and promoting optimal child health and neurodevelopment,” according to lead author Emily Oken, Harvard Medical School professor and chair of the Department of Population Medicine at the Harvard Pilgrim Health Care Institute.
While the benefits of omega-3s are well-established, achieving sufficient intake can be challenging. Dietary sources include fatty fish like salmon, tuna, and sardines. However, concerns about mercury contamination often lead to recommendations for limited consumption. Omega-3 supplements, such as fish oil or algal oil, offer an alternative, but their usage remains suboptimal, particularly among those who do not regularly eat fish.
Disparities in Intake: A Closer Look
The research revealed significant disparities in omega-3 intake based on demographic factors. Older pregnant individuals were more likely to consume fish, while those identifying as non-Hispanic Black, non-Hispanic Asian, or Hispanic reported lower average fish consumption compared to non-Hispanic White individuals. Participants categorized as overweight were also less inclined to eat fish. Interestingly, fish consumption was higher among those who used tobacco or nicotine products, a correlation that warrants further investigation.
Supplement use exhibited a different pattern. It was more prevalent among older individuals with higher levels of education and income, as well as those with a lower body mass index (BMI) and those who already consumed fish. However, crucially, supplement use was less common among those who consumed less fish, creating a heightened risk of deficiency for this group. This suggests a missed opportunity to bridge the nutritional gap through supplementation.
Supplement Use and Risk Factors
The study also found that supplement intake was less common among individuals at higher risk for adverse pregnancy outcomes, specifically those who used tobacco or nicotine products or had a higher BMI. This is particularly concerning, as these individuals may benefit most from the protective effects of omega-3 fatty acids. The reasons for this disparity are complex and likely involve a combination of factors, including socioeconomic barriers, lack of awareness, and healthcare access issues.
Public Health Implications and Recommendations
The findings of this study have significant implications for public health messaging and clinical practice. Given the established benefits of omega-3s and the documented gaps in intake, targeted interventions are needed to ensure adequate nutrition during pregnancy. Dr. Oken emphasizes that “current evidence shows that the benefits of maternal consumption of low-mercury fish, or in its place, omega-3 supplements, outweigh any potential risks.”
The timing of this research is particularly relevant, as both the World Health Organization and the U.S. National Academies are preparing to release reports on the risks and benefits of fish consumption during pregnancy. These reports are expected to provide updated guidance for healthcare professionals and expectant mothers. The study provides valuable data to inform these recommendations and underscores the need for clear, evidence-based advice.
The study team suggests that healthcare providers should proactively discuss omega-3 intake with pregnant patients, encouraging consumption of low-mercury fish and recommending omega-3 supplements for those who do not consume fish regularly. Public health campaigns could also play a role in raising awareness about the importance of omega-3s and providing accessible information about safe and effective ways to increase intake.
Choosing Safe Fish and Supplements
When recommending fish consumption, healthcare providers should advise pregnant individuals to choose options low in mercury, such as salmon, sardines, and trout. The U.S. Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) provide detailed guidance on safe fish choices and consumption limits. The FDA’s website offers a comprehensive chart categorizing fish based on mercury levels.
For those opting for supplements, it’s important to choose a reputable brand that has been third-party tested for purity and potency. Supplements should contain adequate amounts of DHA and EPA, typically at least 500 mg per day, as recommended by many health organizations. It’s also advisable to consult with a healthcare provider before starting any new supplement regimen.
Looking Ahead
Further research is needed to understand the underlying reasons for the observed disparities in omega-3 intake and to develop effective strategies to address them. Future studies could explore the role of cultural factors, food access, and healthcare provider recommendations in shaping dietary habits during pregnancy. Continued monitoring of omega-3 status among pregnant individuals is also essential to track progress and identify emerging trends.
The ECHO program continues to provide valuable insights into the complex interplay of environmental factors and child health. By leveraging large-scale data and collaborative research efforts, the program is helping to pave the way for healthier pregnancies and brighter futures for children across the United States.
The next reports from the World Health Organization and the U.S. National Academies on fish consumption during pregnancy are anticipated later in 2024. These reports are expected to provide updated guidance based on the latest scientific evidence. Stay informed about these developments and discuss your individual needs with your healthcare provider.
Have you discussed your omega-3 intake with your doctor during pregnancy? Share your experiences and thoughts in the comments below. Don’t forget to share this article with anyone who might find it helpful.